Cancer Proteome and Biomarkers

Cancer Proteome and Biomarkers

Proteomics technologies are employed in the discovery of novel therapeutic medicines and for early identification and diagnosis of malignancies. With advancements in the science of proteomics and the use of mass spectrometry, breast cancer observation, prognosis, diagnosis, and treatment are now possible.

With the development of proteomics technology, researchers have been able to distinguish between disease and disease-free states linked with breast cancer. Proteins expressed or discovered in serum, plasma, and tumour cells employing novel approaches provide for a better understanding of cancer heterogeneity. Proteomics in Breast Cancer Proteomics in Skin Cancer Proteomics in Lung Cancer Proteomics in Ovarian Cancer Proteomics in Colorectal Cancer.

 

  • Protein expression services and market analysis
  • Recombinant protein drugs

Related Conference of Cancer Proteome and Biomarkers

March 18-19, 2024

53rd World Congress on Microbiology

Zurich, Switzerland
May 09-10, 2024

16th International Virology Summit

Barcelona, Spain

Cancer Proteome and Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in